<DOC>
	<DOCNO>NCT02827942</DOCNO>
	<brief_summary>Patients infect H. pylorus randomly assign dual therapy vonoprazan 20 mg bid amoxicillin 500 mg tid 1 week triple therapy vonoprazan 20 mg bid , amoxicillin 750 mg bid clarithromycin 200 mg metronidazole 250 mg bid bid 1 week . Success failure eradication determine 13C-urea breath test perform 1 month therapy .</brief_summary>
	<brief_title>Comparison Vonoprazan-based Dual Triple Therapies H. Pylori Eradication</brief_title>
	<detailed_description>Patients infect H. pylorus enrol invite study . Patients never undergo H. pylorus eradication therapy randomly assign dual therapy vonoprazan 20 mg bid amoxicillin 500 mg tid 1 week triple therapy vonoprazan 20 mg bid , amoxicillin 750 mg bid clarithromycin 200 mg bid 1 week . Patients ever fail eradication H. pylori triple therapy contain clarithromycin randomly assign dual therapy vonoprazan 20 mg bid amoxicillin 500 mg tid 1 week triple therapy vonoprazan 20 mg bid , amoxicillin 750 mg bid metronidazole 250 mg bid 1 week . Success failure eradication determine 13C-urea breath test perform 1 month therapy .</detailed_description>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patients infect H. pylorus Patients allergic drug use study Patients agree participate study Patients infect H. pylorus Patients allergic drug use study Patients agree participate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>pylorus</keyword>
</DOC>